What if we could stop cancer before it causes harm? That’s the goal of our Pre-Cancer Atlas project, co-led by our Dr. Eduardo Vilar-Sanchez and Dr. Anirban Maitra: fal.cn/3jDde Eduardo Vilar Anirban Maitra #CancerMoonshot #EndCancer

Anviron - Orphan drug developer. Oncology and immunological diseases fundable.com/anviron via Fundable

Thank you Zack Capp for raising awareness!

Great news from @panCAN - Mortality rates for Pancreatic Cancer are falling. pancan.org/news/five-year…

Congratulations to Applied Pharmaceutical on their approved IND for APS03118, a promising candidate to treat solid tumors with the RET mutation. Best of luck to the team.

Excellent news this morning, US Congress has approved $15m for pancreatic cancer research. We need as much support as we can to fight this horrific disease - bit.ly/3J9ZRo4

#Zenith Epigenetics is initiating their Phase 2b trial for their candidate tackling #TNBC, a horrific disease that desperately needs improved treatment options. Wishing the team success - bit.ly/3GgOLgx

Congratulations Incyte for their recent FDA approval of Opzelura, the first repigment cream to treat #vitiligo, a skin related autoimmune condition affecting 1 in a 100 people. Well done team! bit.ly/3yUiHf4

Jack Singer M.D. joins Anviron Board of Advisors. Dr. Singer is a pioneer oncologist where at Fred Hutchinson and later, the VA, in using bone marrow transplants to improve oncology therapies. #pancreaticcancer #pdac #TNBC - anviron.com/about-us

We look forward to joining our colleagues FierceBiotech next week in Boston. #oncology

Congratulations to Eli Lilly and the #retevmo team for their recent FDA approval of Selpercatinib for the treatment of non-small cell lung cancer. Well done! bit.ly/3WrXeVF

Thank you PanCAN for all you do to raise awareness for this devastating disease during Pancreatic Cancer Awareness Month! . Your hard word is appreciated!

Cancers hijack the synthesis of cell surface membrane proteins so tumors can hide from our immune system & resist chemotherapy. We are developing drugs that disrupt this cancer behavior and are excited to announce our candidate ANV221 was awarded a US Patent.

The Anviron team is resolute in our support for our Israeli friends and colleagues. Our hearts go out to the victims of these horrific attacks and we strongly condemn the barbaric violence against innocent civilians.

Please join the Anviron team in recognizing World Pancreatic Cancer Day! Show your support by participating in a PurpleStride 2024 event near you. - secure.pancan.org/site/SPageServ…

Thank you Daniel Morgan!

Anviron team has produced a brief summary of exciting progress with drug-resistant, Her2+ breast cancers. Thank you to the Anviron team for putting this together. youtu.be/JIF0IrdBLvU

The degree our drug candidate, ANV221, re-sensitizes Her2-positive, drug-resistant breast cancers to trastuzumab and other anti-Her2 drugs is being studied. Results will be announced this summer.